Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pax-2, kidney development, and oncogenesis

G R Dressler1

  • 1Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109, USA.

Medical and Pediatric Oncology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kielin/Chordin-Like Protein-A Novel Pathway to Prevent Renal Fibrosis?: Kielin/Chordin-Like Protein, a Novel Enhancer of BMP Signaling, Attenuates Renal Fibrotic Disease. Nat Med 11: 387-393, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Another niche for Notch.

Kidney international·2008
Same author

Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene.

Development (Cambridge, England)·2001
Same author

PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Nucleic acids research·2000
Same author

Kidney development in cadherin-6 mutants: delayed mesenchyme-to-epithelial conversion and loss of nephrons.

Developmental biology·2000
Same author

Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.

Developmental biology·2000
Same journal

Kaposiform hemangioendothelioma and therapy with interferon-alpha.

Medical and pediatric oncology·2003
Same journal

Importance of informed consent in offering to return research results to research participants.

Medical and pediatric oncology·2003
Same journal

Tumor lysis syndrome and neuroblastoma.

Medical and pediatric oncology·2003
Same journal

High incidence of brain tumors of childhood in Hungary between 1989 and 2001.

Medical and pediatric oncology·2003
Same journal

Surviving childhood cancer: what next? Issues under consideration at the After Completion of Therapy (ACT) clinic in India.

Medical and pediatric oncology·2003
Same journal

Local control in childhood extremity sarcomas: salvaging limbs and sparing function.

Medical and pediatric oncology·2003
See all related articles

Pax-2 gene regulation is crucial for kidney development and function. Dysregulation, including failure to suppress Pax-2 in mature kidneys, contributes to renal diseases like Wilms' tumors.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Nephrology

Background:

  • Tissue development requires precise gene regulation.
  • Pax-2 is a key transcription factor in kidney development, essential for renal epithelium differentiation.
  • Failure to suppress Pax-2 in mature kidney cells impairs renal function.

Purpose of the Study:

  • To investigate the role of Pax-2 in kidney development and disease.
  • To explore the regulatory relationship between WT1 and Pax-2.
  • To understand how Pax-2 dysregulation contributes to renal pathologies.

Main Methods:

  • Analysis of gene expression patterns during kidney development.
  • Investigating the function of Pax-2 in renal progenitor cells.
  • Studying the interaction between Wilms' tumor suppressor gene (WT1) and Pax-2.

Related Experiment Videos

Main Results:

  • Pax-2 is expressed in critical kidney progenitor cells.
  • Pax-2 function is required for renal epithelial differentiation.
  • WT1 may down-regulate Pax-2 expression, explaining high Pax-2 levels in Wilms' tumors.
  • Reactivation of Pax-2 in mature kidneys is linked to renal diseases.

Conclusions:

  • Pax-2 is a vital developmental regulator in the kidney.
  • Aberrant Pax-2 expression and regulation are implicated in various renal diseases.
  • Understanding WT1-Pax-2 interactions is key to addressing kidney pathologies.